Pharmacy Hazardous Compounding Contingency Southern Nevada Health Care System

The Department of Veterans Affairs has issued a sources-sought notice for a contingency contract to provide pharmacy hazardous compounding services for the Southern Nevada Healthcare System (VASNHCS). The contract scope involves the compounding and delivery of antineoplastic hazardous drugs from an FDA 503A-compliant pharmacy licensed in Nevada, supplying chemotherapy treatments for up to 15 patients per day, Monday through Friday, over a five-year period from October 1, 2026, through September 30, 2031. The compounded sterile products must comply with USP <797> for sterile compounding and USP <800> for hazardous drug handling, including strict packaging, labeling, and transport standards ensuring medications have a minimum of 12 hours remaining on their Beyond-Use Date (BUD) at delivery. Deliveries are required to the inpatient pharmacy at the VA Southern Nevada Healthcare System in North Las Vegas, NV, with next-business-day delivery by 9:00 a.m., including the capability to meet STAT orders under defined conditions. The contract contains detailed requirements for regulatory compliance, including mandated accreditation, documentation, and quality assurance such as providing stability data, certification reports, and inspection results on demand. Special contract clauses impose stringent security, data protection, and privacy standards limiting contractor access to VA IT systems, requiring encryption of sensitive data, and mandating prompt breach notification and liquidated damages for data privacy violations. The contractor must maintain designated points of contact with authority over daily contract performance and must respond to complaints within three business days. Invoicing will be itemized and no advance payments are authorized. Packaging and transportation must meet all applicable carrier regulations, but no military standards are invoked. The solicitation does not include a finalized list of FAR clauses or evaluation factors but anticipates assessment based on regulatory compliance, technical capability, and operational performance. This notice is a market research step to inform future solicitations, with no contract value or award mechanism currently established, and proposals are limited to 10 double-sided pages submitted electronically by a stated deadline.